GRAIL to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting
GRAIL has announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting. These new data evaluate the performance of GRAIL’s test in symptomatic participants with suspicion of cancer. Today, the majority of deadly cancers do not have screening tests that are recommended by guidelines, and as a result, most cancers aren’t detected util they have progressed to late stages when chances of survival are much lower. There is a great...